Friday, October 30, 2020 10:28:36 AM
Agree, the ball has been dropped badly here. Data is great, but building awareness has to be there. It isn't. Sux. How many Remdesivirs are we going to see before Avi is even noticed by the planet? If these guys are so confident in the results, spin it FFS, so that the pressure is there to move it through the approval process.
Essentially, no one in the US knows about this drug...and people that could live through Covid are dying instead.
Essentially, no one in the US knows about this drug...and people that could live through Covid are dying instead.
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
